Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions |
umls-concept:C0021822,
umls-concept:C0205155,
umls-concept:C0237123,
umls-concept:C0348026,
umls-concept:C0456205,
umls-concept:C0678594,
umls-concept:C1512888,
umls-concept:C1522472,
umls-concept:C1550605,
umls-concept:C1551341,
umls-concept:C1552858,
umls-concept:C1552923,
umls-concept:C1552924,
umls-concept:C1705191,
umls-concept:C2347947
|
| pubmed:issue |
1-2
|
| pubmed:dateCreated |
1998-10-6
|
| pubmed:abstractText |
After reviewing currently available diagnostic assessment instruments for substance use disorders this paper describes the format and structure of the Munich-Composite International Diagnostic Interview (M-CIDI) substance disorder section. In addition, the test-retest reliability of diagnoses and criteria for nicotine, alcohol, illegal and prescription drugs, is reported. Findings obtained in community sample of adolescents and young adults indicate that the substance section is acceptable for almost all types of respondents, efficient in terms of time and ease of administration as well as reliable in terms of consistency of findings over time. The test-retest reliability over a period of an average of 1 month, as examined by two independent interviewers indicates good-to-excellent kappa values for all substance disorders assessed, with significant kappa values ranging between 0.55 for drug abuse and 0.83 for alcohol abuse. There was also fairly consistently high agreement for the assessment of single DSM-IV diagnostic criteria for abuse and dependence as well as the M-CIDI quantity-frequency and time-related questions. To conclude, although - unlike previous studies - this study was conducted in a community sample and not in patients and used considerably longer time intervals of more than a month between investigations, our M-CIDI reliability findings are at least as high as those from previous studies.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Mar
|
| pubmed:issn |
1022-6877
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
4
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
28-41
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:9740815-Adolescent,
pubmed-meshheading:9740815-Adult,
pubmed-meshheading:9740815-Age Factors,
pubmed-meshheading:9740815-Alcohol Drinking,
pubmed-meshheading:9740815-Alcoholic Beverages,
pubmed-meshheading:9740815-Alcoholism,
pubmed-meshheading:9740815-Epidemiologic Methods,
pubmed-meshheading:9740815-Female,
pubmed-meshheading:9740815-Humans,
pubmed-meshheading:9740815-Male,
pubmed-meshheading:9740815-Middle Aged,
pubmed-meshheading:9740815-Psychiatric Status Rating Scales,
pubmed-meshheading:9740815-Psychometrics,
pubmed-meshheading:9740815-Reproducibility of Results,
pubmed-meshheading:9740815-Substance-Related Disorders,
pubmed-meshheading:9740815-Terminology as Topic,
pubmed-meshheading:9740815-Tobacco Use Disorder,
pubmed-meshheading:9740815-World Health Organization
|
| pubmed:year |
1998
|
| pubmed:articleTitle |
Structure, content and reliability of the Munich-Composite International Diagnostic Interview (M-CIDI) substance use sections.
|
| pubmed:affiliation |
Max Planck Institute of Psychiatry, Clinical Psychology and Epidemiology Unit, Munich, Germany.
|
| pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|